Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2014


Biologics R&D Leaders Forum

25 Feb 2014 - 27 Feb 2014 - Brussels, Belgium



Bookmark and Share


This three-day event will develop upon the previous, highly successful meeting to further provide focused and in depth industry, regulatory and scientific perspectives in terms of what the factors are that hinder the progression of biologics in clinical development. Industry experts will talk about their experiences and give insight into the vital components that make up a successful early-stage strategy for biologic studies.

 4 EVENTS IN ONE:

  • Best Practices in Developing Complex Biologics
  •  Best Practices in Developing Innovative Advanced Biological Therapies
  •  Enhancing PK/PD Understanding for Complex Biologicals
  • Optimising CMC in Parallel to Biologic R&D Processes

 The attendees of this event will obtain an advanced understanding of how to strategically incorporate the requirements that are specific to biologics into the operational planning for an early-phase clinical trial that provides the best opportunity to save time, reduce risk, cut costs, and demonstrate product value early in development.

To request the full agenda please follow the link:

http://biologic2014.nextlevelpharma.com/request-agenda



Further information
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Ribosome Recycling as a Drug Target
Researchers explain mechanism that recycles bacterial ribosomes stalled on messenger RNAs that lack termination codons.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!